Utama › Kanser Serviks
Kajian klinikal Kanser Serviks sedang mengambil peserta di AS
114 kajian untuk Kanser Serviks sedang mengambil peserta di lokasi seluruh Amerika Syarikat.
Bandar dengan paling banyak kajian
- Houston, TX34 kajian
- Nashville, TN19 kajian
- New York City, NY19 kajian
- Boston, MA18 kajian
- Los Angeles, CA16 kajian
- Arlington, VA16 kajian
- San Antonio, TX14 kajian
- St. Louis, MO13 kajian
- Dallas, TX13 kajian
- Orlando, FL12 kajian
- Chicago, IL12 kajian
- Atlanta, GA11 kajian
- Columbus, OH11 kajian
- Baldwin Park, CA11 kajian
- Philadelphia, PA10 kajian
- San Diego, CA10 kajian
- Edison, NJ10 kajian
- Cleveland, OH10 kajian
- Queens, NY10 kajian
- Durham, NC9 kajian
- Portland, OR9 kajian
- Washington, DC9 kajian
- Miami, FL9 kajian
- Minneapolis, MN9 kajian
- Birmingham, AL8 kajian
- Baltimore, MD8 kajian
- Rochester, MN7 kajian
- New Orleans, LA7 kajian
- Seattle, WA7 kajian
- Jacksonville, FL7 kajian
- Denver, CO7 kajian
- Oklahoma City, OK7 kajian
- Pittsburgh, PA7 kajian
- Grand Rapids, MI6 kajian
- San Francisco, CA6 kajian
- Santa Monica, CA6 kajian
- New Haven, CT6 kajian
- Salt Lake City, UT6 kajian
- Austin, TX6 kajian
- Cincinnati, OH5 kajian
Mengikut negeri
- Alabama9 kajian
- Arizona8 kajian
- Arkansas3 kajian
- California38 kajian
- Colorado12 kajian
- Connecticut9 kajian
- Florida29 kajian
- Georgia15 kajian
- Illinois15 kajian
- Indiana5 kajian
- Iowa5 kajian
- Kansas3 kajian
- Kentucky7 kajian
- Louisiana8 kajian
- Maryland12 kajian
- Massachusetts19 kajian
- Michigan14 kajian
- Minnesota18 kajian
- Mississippi3 kajian
- Missouri13 kajian
- Nebraska4 kajian
- Nevada5 kajian
- New Jersey13 kajian
- New Mexico4 kajian
- New York23 kajian
- North Carolina14 kajian
- Ohio24 kajian
- Oklahoma11 kajian
- Oregon10 kajian
- Pennsylvania15 kajian
- Rhode Island4 kajian
- South Carolina6 kajian
- Tennessee21 kajian
- Texas45 kajian
- Utah10 kajian
- Virginia20 kajian
- Washington10 kajian
- West Virginia3 kajian
- Wilayah Columbia5 kajian
- Wisconsin7 kajian
Kajian yang dikemas kini baru-baru ini
Teks kajian rasmi (Bahasa Inggeris)
Distance-Based Exercise to Preserve Function and Prevent Disability
Mengambil peserta
Umur 18 ke atas · Semua jantina · Dikemas kini 2 Okt 2026 · NCT07059884A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 2 Okt 2026 · NCT06465069A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 2 Okt 2026 · NCT06760819Hyaluronic Acid-based Gel Spacers in Gynecologic Malignancies
Mengambil pesertaFasa 1
Umur 18 ke atas · Wanita · Dikemas kini 1 Okt 2026 · NCT07292818A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 1 Okt 2026 · NCT06172478177Lu-BetaBart in Patients With Relapsed/Refractory, Locally Advanced Inoperable, or Metastatic Solid Tumors
Mengambil pesertaFasa 1/2
Umur 18 ke atas · Semua jantina · Dikemas kini 1 Okt 2026 · NCT07189871The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 30 Sep 2026 · NCT07285044Leveraging Methylated DNA Markers (MDMs) in the Detection of Endometrial Cancer, Ovarian Cancer, and Cervical Cancer
Mengambil pesertaKajian pemerhatian
Umur 18 ke atas · Wanita · Dikemas kini 29 Sep 2026 · NCT05051722DESTINY-PANTUMOUR04
Mengambil pesertaKajian pemerhatian
Umur 18 hingga 130 · Semua jantina · Dikemas kini 25 Sep 2026 · NCT07124000Ocular Assessments in Patients Treated With Tivdak® in Recurrent or Metastatic Cervical Cancer
Mengambil pesertaFasa 4
Umur 18 ke atas · Wanita · Dikemas kini 25 Sep 2026 · NCT06952660A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) as First-line Maintenance Treatment of Cervical Cancer (MK-2870-036/TroFuse-036/GOG-3123/ENGOT-cx22)
Mengambil pesertaFasa 3
Umur 18 ke atas · Wanita · Dikemas kini 25 Sep 2026 · NCT07216703A Study of KIVU-107 in Participants With Locally Advanced or Metastatic Solid Tumors
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 24 Sep 2026 · NCT07229313Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
Mengambil pesertaFasa 1/2
Umur 18 ke atas · Semua jantina · Dikemas kini 24 Sep 2026 · NCT06047379Radiation Combined With BIspecific T-Cell Engager in DLL3 Expressing Tumors
Mengambil pesertaFasa 1/2
Umur 18 hingga 99 · Semua jantina · Dikemas kini 22 Sep 2026 · NCT06814496Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 21 Sep 2026 · NCT05983432A Study of Ivonescimab in People With Endometrial and Cervical Cancers
Mengambil pesertaFasa 2
Umur 18 ke atas · Wanita · Dikemas kini 21 Sep 2026 · NCT06925724Fecal Microbiota Transplantation in Treating Immune-Checkpoint Inhibitor Induced-Diarrhea or Colitis in Genitourinary Cancer Patients
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 18 Sep 2026 · NCT04038619A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations
Mengambil pesertaFasa 1/2
Umur 18 ke atas · Semua jantina · Dikemas kini 17 Sep 2026 · NCT07109726PROton Therapy for Post Surgical Treatment of GYNecologic Cancer
Mengambil pesertaFasa 2
Umur 18 ke atas · Wanita · Dikemas kini 17 Sep 2026 · NCT05758688Triage of Advanced Cervical Cancer Through Immunotherapy Induction (TRACTION)
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 17 Sep 2026 · NCT05475171Establishing a Tumor Registry for Patients With Neuroendocrine Carcinoma of the Cervix
Mengambil pesertaKajian pemerhatian
Semua umur · Semua jantina · Dikemas kini 14 Sep 2026 · NCT04723095GI-101/GI-101A as a Single Agent or in Combination With Pembrolizumab or Lenvatinib in Advanced Solid Tumors
Mengambil pesertaFasa 1/2
Umur 18 ke atas · Semua jantina · Dikemas kini 14 Sep 2026 · NCT04977453Study of Volrustomig as Monotherapy or in Combination With Anti- Cancer Agents in Participants With Advanced/Metastatic Solid Tumors
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 11 Sep 2026 · NCT06535607Pembrolizumab and Lenvatinib in Advanced Cervical Cancer
Mengambil pesertaFasa 2
Umur 18 ke atas · Wanita · Dikemas kini 10 Sep 2026 · NCT04865887Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 10 Sep 2026 · NCT06293898Daripada ClinicalTrials.gov, data diperoleh pada 4 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.